We constantly look for partners to help us expand our reach, knowledge base, and development pipeline

Two men shake hands in business exchange.png

Pipeline Expansion

Selective product in-licensing or acquisition will enable Vallon Pharmaceuticals to rapidly build a diversified pipeline of drugs to treat CNS disorders.


SOURCE.  Academia, startup, or pharma


STAGE.  Preclinical development through Phase 2-ready


TYPE.  Small molecule – NCE or reformulation with novel IP

Corporate Alliances

Vallon has developed ADAIR in collaboration with Lonza’s formulation development team in Edinburgh, Scotland

Patient and Professional Organizations

Vallon supports and/or collaborates with a variety of Professional and Patient Advocacy Organizations, including: